Jasmine Zain, M.D., director, T Cell Lymphoma Program
Diagnosis, treatment and cure rates for lymphoma are improving every year, and research at City of Hope has helped to fuel those trends and improve outcomes among our patients.
Leading-edge clinical trials, collaborations with a large network of institutions and our designation as a lymphoma Specialized Program of Research Excellence provide our patients with exciting new treatment options. And City of Hope’s unique ability to produce and manufacture the agents being developed by our investigators means treatments get to our patients faster.
Experts in cutaneous lymphoma
Cutaneous lymphomas are rare diseases — most physicians see very few cases in their lifetime. City of Hope is one of the only cancer centers in the country with skin lymphoma experts, who saw and treated hundreds of patients since 2015. They have helped develop treatment guidelines and are pioneering modern therapies for:
- Cutaneous T cell lymphoma
- Follicle center lymphoma
- Marginal zone B cell lymphoma
- Diffuse large B cell lymphomas of the leg and other areas
These are some of the most difficult lymphomas to diagnose since they resemble other common skin conditions like eczema, psoriasis and ringworm. Our team includes dermatopathologists able to discern subtle differences between skin lymphoma subtypes, and are responsible for developing groundbreaking skin-directed and light therapies used to treat them once they are diagnosed.